BioCentury | Jul 27, 2017
Product R&D

Spheres of influence

...development services. According to InSphero CEO Jan Lichtenberg, the study began as separate projects between InSphero...
...spheroids efficiently. InSphero holds a patent on its microtissue manufacturing process (see “InSphero’s Spheroids”). Figure: InSphero’s...
...short and long-term tox data. Source: InSphero AG Each spheroid contains roughly 1,000 cells. Simon Messner, InSphero’s...
BioCentury | May 12, 2017
Company News

InSphero, NCATS partner to assess screening platform for anticancer agents

...agreement (CRADA). InSphero AG , Schlieren, Switzerland National Institutes of Health , Bethesda, Md. Business: Cancer Julian Zhu InSphero AG National...
BioCentury | Jul 13, 2015
Financial News

InSphero completes venture financing

InSphero AG , Schlieren, Switzerland Business: Supply/Service Date completed: 2015-07-08 Type: Venture financing Raised: CHF20 million ($21.3 million) Investor: HP Wild Holding WIR Staff...
Items per page:
1 - 3 of 3
BioCentury | Jul 27, 2017
Product R&D

Spheres of influence

...development services. According to InSphero CEO Jan Lichtenberg, the study began as separate projects between InSphero...
...spheroids efficiently. InSphero holds a patent on its microtissue manufacturing process (see “InSphero’s Spheroids”). Figure: InSphero’s...
...short and long-term tox data. Source: InSphero AG Each spheroid contains roughly 1,000 cells. Simon Messner, InSphero’s...
BioCentury | May 12, 2017
Company News

InSphero, NCATS partner to assess screening platform for anticancer agents

...agreement (CRADA). InSphero AG , Schlieren, Switzerland National Institutes of Health , Bethesda, Md. Business: Cancer Julian Zhu InSphero AG National...
BioCentury | Jul 13, 2015
Financial News

InSphero completes venture financing

InSphero AG , Schlieren, Switzerland Business: Supply/Service Date completed: 2015-07-08 Type: Venture financing Raised: CHF20 million ($21.3 million) Investor: HP Wild Holding WIR Staff...
Items per page:
1 - 3 of 3